Effects of Phenobarbital and Prednisolone on Neurological Signs of Canine Distemper
Open Access
- 20 August 2025
- journal article
- Published by Wiley in Veterinary Medicine and Science
- Vol. 11 (5) , e70479
Abstract
Background: Canine distemper virus (CDV) is a highly infectious and often fatal disease in dogs, affecting various systems. Despite vaccination efforts, cases of distemper, especially the neurological form, remain a global concern due to its high fatality rate.Objective: To investigate the effectiveness of phenobarbital and prednisolone in treating the neurological form of canine distemper (CD).Methods: Thirty‐five dogs with neurological signs of CD were included in the study after careful clinical examination. Confirmation of CD was based on clinical signs, rapid diagnostic tests, and RT‐PCR testing of blood and/or cerebrospinal fluid (CSF). Dogs were treated with oral phenobarbital (2.5 mg/kg) and prednisolone (0.55 mg/kg) every 12 h. Treatment outcomes were categorised as recovered, died, or euthanised.Results: Out of the 35 dogs, 25 tested positive for CDV. Among positive cases (n = 25), two dogs mostly recovered, one dog partially recovered, one dog remained unchanged, 18 died (15 died naturally and three were euthanised), and three dogs were lost to follow‐up. In the negative test group (10 dogs), eight dogs died, the outcome of one dog was unknown and one dog remained unchanged. Disease duration ranged from 2 to 586 days (average: 72 days in positive cases, 59.2 days in negative cases). The low recovery rate (8%) suggests limited effectiveness of the treatments used, including prednisolone, particularly for myoclonus, which was the most frequent clinical sign. Regarding seizure management, while our study observed some effectiveness of phenobarbital in controlling seizures, it's important to note that the efficacy of phenobarbital can vary.Limitations: Small sample size and owner non‐compliance limited the study.Conclusions: Our findings suggest limited benefit from prednisolone for neurological CD. Further research is necessary to develop more effective treatment strategies for this devastating canine viral disease.Keywords
This publication has 14 references indexed in Scilit:
- Evaluation of the Efficacy and Safety of Silver Nanoparticles in the Treatment of Non-Neurological and Neurological Distemper in Dogs: A Randomized Clinical TrialViruses, 2022
- Multiple Receptors Involved in Invasion and Neuropathogenicity of Canine Distemper Virus: A ReviewViruses, 2022
- Detection of canine distemper virus in cerebrospinal fluid, whole blood and mucosal specimens of dogs with distemper using RT‐PCR and immunochromatographic assaysVeterinary Medicine and Science, 2022
- Central nervous system lesions caused by canine distemper virus in 4 vaccinated dogsJournal of Veterinary Diagnostic Investigation, 2021
- Antiviral efficacy of favipiravir against canine distemper virus infection in vitroBMC Veterinary Research, 2019
- Application of xenogeneic anti‐canine distemper virus antibodies in treatment of canine distemper puppiesJournal of Small Animal Practice, 2016
- Epidemiology and clinical presentation of canine distemper disease in dogs and ferrets in Australia, 2006–2014Australian Veterinary Journal, 2016
- Immunopathogenic and Neurological Mechanisms of Canine Distemper VirusAdvances in Virology, 2012
- Acute canine distemper encephalitis is associated with rapid neuronal loss and local immune activationJournal of General Virology, 2009
- Pathogenesis and immunopathology of systemic and nervous canine distemperVeterinary Immunology and Immunopathology, 2009